Viatrexx-Mesenchyme

Product NDC

73069-102

11-digit product format

730690102

Labeler code

73069

Product ID

73069-102_89209558-f60d-405c-a164-e41324db780c

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Adrenal, Ascorbic Acid, BDNF, DHEA, Malic acid, bFGF, Fucus vesiculosus, Histidine, Hyaluronidase, IL-6, Lactic acid, Lymph node, Mesenchyme, NAD, Natrum oxalaceticum, Natrum pyruvicum, Natrum sulphuricum, Phenylalanine, Amino Acid, Pyrogenium, Thuja occidentalis, Trichinoyl, Tyrosine

Dosage form

INJECTION

Route

INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS

Labeler

VIATREXX BIO INCORPORATED

Marketing category

UNAPPROVED DRUG OTHER

Marketing start

2019-03-29

Marketing end

0000-00-00

Substance

BOS TAURUS ADRENAL GLAND; SUS SCROFA ADRENAL GLAND; ASCORBIC ACID; BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN; PRASTERONE; MALIC ACID; BASIC FIBROBLAST GROWTH FACTOR (HUMAN); FUCUS VESICULOSUS; HISTIDINE; HYALURONIDASE; HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED); LACTIC ACID; SUS SCROFA LYMPH VESSEL; BOS TAURUS LYMPH VESSEL; SUS SCROFA MESENCHYME; NADIDE; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SODIUM SULFATE; PHENYLALANINE; PROLACTIN; RANCID BEEF; THUJA OCCIDENTALIS LEAF; DODECAHYDROXYCYCLOHEXANE DIHYDRATE; TYROSINE

Active strength

201 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL

Pharmacologic classes

Vitamin C [EPC],Ascorbic Acid [CS],Endoglycosidase [EPC],Glycoside Hydrolases [CS]

NDC exclude flag

No

Listing certified through

2020-12-31

Current FDA listing

Historical FDA.report record